BOSTON SCIENTIFIC CORPORATION Business Acquisition, Purchase Price Allocation, Notes Payable and Long-term Debt (Deprecated 2013-01-31)
BOSTON SCIENTIFIC CORPORATION (BSX) had Business Acquisition, Purchase Price Allocation, Notes Payable and Long-term Debt (Deprecated 2013-01-31) of $0 as of 2013-11-01, per its 10-K filed 2014-02-26.
Discontinued › Notes › Business Combinations
us-gaap:BusinessAcquisitionPurchasePriceAllocationNotesPayableAndLongTermDebt · last filed 2014-02-26
- 2013-11-01: Business Acquisition, Purchase Price Allocation, Notes Payable and Long-term Debt (Deprecated 2013-01-31) $0.00.
| Period end | Business Acquisition, Purchase Price Allocation, Notes Payable and Long-term Debt (Deprecated 2013-01-31) |
|---|---|
| 2013-11-01 | $0.00 10-K · filed 2014-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |